Melanotan Il Acetate (10 Mg)

Melanotan II is a cyclic heptapeptide, structurally modified to enhance:

• Receptor affinity

• Resistance to enzymatic degradation

• Duration of biological activity

The acetate salt form improves stability and solubility for pharmaceutical preparation. The “10 mg” designation refers solely to the total peptide content per vial, not a mode of action.

Melanotan ll i snon-selective, meaning it activites multiple melanocortin receptors, primarily:

• MC1R - skin pigmentation

• MC3R & MC4R — appetite, energy balance, libido

This multi-receptor activity explains its diverse systemic effects.

MCiR Activation (Skin)

In melanocytes, Melanotan II:

• Stimulates tyrosinase activity

• Increases melanin synthesis

• Shifts melanin production toward eumelanin (dark, UV-protective pigment)

Key characteristics:

• Pigmentation occurs independently of UV exposure

• UV light, if present, amplifies and stabilizes the effect

• Darkening is gradual and systemic, not spot-specific

Importantly, this pigmentation is hormonal, not cosmetic—it reflects altered cellular behavior rather than surface staining.

MC3R / MC4R Activation (Central Nervous System)

Within the hypothalamus, Melanotan II:

• Suppresses appetite signaling pathways

• Enhances satiety perception

• Reduces reward-driven food intake

This occurs through the melanocortin energy-homeostasis network, a system also implicated in genetic obesity disorders.

The appetite effect is secondary, not the compound's primary design, but is mechanistically robust.